Dr. Sudha Seshadri’s keynote speech will focus on the research and treatment of Alzheimer’s and other dementias.
Thursday, March 20, 2025
Networking: 11 to 11:30 a.m.
Program: 11:30 a.m. to 1 p.m.
Brookhaven Country Club
3333 Golfing Green Dr.
Farmers Branch, Texas
Directions to event location (PDF).
View photos from our 2024 luncheons on our Facebook page.
View Program (PDF)
/*Start: Hide post event*/
Register Now Support with Donation
/*End: Hide post event*/
Featured Speaker:
Radical Nonviolent Peacemaking Strategies – Secrets from the Women of the Torah
Dr. Sudha Seshadri, M.D., Director
Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases
University of Texas Health Science Center, San Antonio
Professor of Neurology, Psychiatry and Cellular and Integrative Physiology
Joe R. and Teresa Lozano Long School of Medicine, San Antonio
Professor Sudha Seshadri, M.D., is a behavioral neurologist and the Robert R. Barker Distinguished University Professor of Neurology, psychiatry and cellular and integrative physiology at the Joe R. and Teresa Lozano Long School of Medicine, University of Texas Health Sciences Center, San Antonio.
Since December 2017, she has served as the founding director of the Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases which was awarded a National Institute on Aging designated Alzheimer Disease Research Center (ADRC), the South Texas ADRC in 2021.
The Biggs Institute combines comprehensive, compassionate, continuing clinical care for a broad range of vascular and neurodegenerative diseases with basic, computational and epidemiological research, community outreach, advocacy, training and education with a special emphasis on bringing the most advanced precision prevention, diagnosis and treatment approaches to the underserved Hispanic communities in south Texas.
Dr. Seshadri completed her medical education and residency training in internal medicine and neurology at the Christian Medical College, Vellore, India, the Madras Medical College, Chennai, India, and at the All India Institute of Medical Sciences in New Delhi. She later completed a second residency at Boston University, Boston, along with fellowship training in the neurobiology of aging and in neuroepidemiology at the University of Massachusetts Medical Center in Worcester, Massachusetts, and the National Heart, Lung and Blood Institute’s Framingham Heart Study, Bethesda, Maryland, where she remains a senior investigator, with an adjunct appointment as professor of neurology at Boston University, Boston.
Her research interests are in uncovering the biology of Alzheimer’s disease and related dementias, stroke and vascular brain injury through epidemiological, genetic, multi-omic and biomarker studies on large, population-based cohorts. In parallel, she continues to see patients and lead clinical trials of promising therapies. She has received over $95 million in grant funding from the National Institutes of Health, has over 500 peer-reviewed publications, has mentored over 45 physicians and scientists and won awards as a teacher, clinician and researcher, including election to Alpha Omega Alpha and the Association of American Physicians. She has lectured extensively, nationally and internationally and leads several national and international consortia. She is a recognized thought leader in Alzheimer’s disease and has been featured over 150 times in the lay media. Her goal is to leave a legacy of effective preventive or therapeutic interventions for dementia, and a cadre of dedicated and caring clinicians and scientists whom she has helped empower.
More
/*Start: Hide post event*/
R.S.V.P. by March 3, 2025
Sponsorship Opportunities Available
/*End: Hide post event*/
For more information, contact:
Debbie Rohrich-Tyler | 314-633-7032 | drohrichtyler@ssndcp.org